Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography

• Status: Completed
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Zolpidem

Criteria

Inclusion Criteria:

• Patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10

Exclusion Criteria:

• Patients with schizophrenia or manic-depressive illness

• Patients with insomnia caused by physical diseases

• Patients having a history of hypersensitivity to zolpidem

• Patients with attention-deficit hyperactivity disorder